Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Sulkowski

Showing results (31-40 of 206) with videos related to

Pageof 21
Sort By:
Journal of Addictive Diseases|August 7, 2008
Detection of liver disease in injection drug usersDavid L Thomas, Mark S Sulkowski
The Medical Clinics of North America|March 31, 2023
Chronic Hepatitis C: Advances in Therapy and the Remaining ChallengesSaleh A Alqahtani, Mark S Sulkowski
The Journal of Infectious Diseases|November 27, 2020
Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the DifficultOluwaseun Falade-Nwulia, Mark S Sulkowski
Annals of Internal Medicine|February 1, 2003
Hepatitis C in the HIV-Infected PersonMark S Sulkowski, David L Thomas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
About This Continuing Medical Education ActivityDavid Wyles, Mark S Sulkowski, Douglas Dieterich
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral TherapyDavid L Wyles, Mark S Sulkowski, Douglas Dieterich
JAMA|May 4, 2002
Needlestick transmission of hepatitis CMark S Sulkowski, Stuart C Ray, David L Thomas
Hepatology (Baltimore, Md.)|March 29, 2014
Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individualsLiesl M Hagan, Mark S Sulkowski, Raymond F Schinazi
The New England Journal of Medicine|April 18, 2014
Daclatasvir plus sofosbuvir for HCV infectionMark S Sulkowski, Ira M Jacobson, David R Nelson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Treatment of chronic hepatitis B in HIV-infected persons: thinking outside the black boxChloe L Thio, Mark S Sulkowski, David L Thomas
Pageof 21

Showing results (31-40 of 206) with videos related to

Sort By:
Pageof 21
Journal of Addictive Diseases|August 7, 2008
Detection of liver disease in injection drug usersDavid L Thomas, Mark S Sulkowski
The Medical Clinics of North America|March 31, 2023
Chronic Hepatitis C: Advances in Therapy and the Remaining ChallengesSaleh A Alqahtani, Mark S Sulkowski
The Journal of Infectious Diseases|November 27, 2020
Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the DifficultOluwaseun Falade-Nwulia, Mark S Sulkowski
Annals of Internal Medicine|February 1, 2003
Hepatitis C in the HIV-Infected PersonMark S Sulkowski, David L Thomas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
About This Continuing Medical Education ActivityDavid Wyles, Mark S Sulkowski, Douglas Dieterich
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral TherapyDavid L Wyles, Mark S Sulkowski, Douglas Dieterich
JAMA|May 4, 2002
Needlestick transmission of hepatitis CMark S Sulkowski, Stuart C Ray, David L Thomas
Hepatology (Baltimore, Md.)|March 29, 2014
Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individualsLiesl M Hagan, Mark S Sulkowski, Raymond F Schinazi
The New England Journal of Medicine|April 18, 2014
Daclatasvir plus sofosbuvir for HCV infectionMark S Sulkowski, Ira M Jacobson, David R Nelson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Treatment of chronic hepatitis B in HIV-infected persons: thinking outside the black boxChloe L Thio, Mark S Sulkowski, David L Thomas
Pageof 21